Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceGeneral health

Alfalfa

An old "blood purifier" and green-food tablet whose only respectable human data — an LDL reduction — came from eating around 120 g of alfalfa seeds a day, not from tablets. It also contains L-canavanine, an amino acid linked to lupus-like autoimmune reactions, which makes the risk-benefit unusually poor for a routine green supplement.

What the science says

  • Lowers cholesterol Limited evidence

    The frequently cited finding is a small 1987 study in which patients with type II hyperlipoproteinaemia ate 40 g of heat-prepared alfalfa seeds three times daily and saw meaningful falls in LDL cholesterol and apolipoprotein B, attributed to saponins binding bile acids. That is roughly 120 g of seed per day in eight patients — nothing like the 500-1000 mg leaf tablets sold today, and it has never been replicated in a modern controlled trial.

  • Relieves menopausal symptoms via phytoestrogens Limited evidence

    Alfalfa contains coumestrol and other coumestan phytoestrogens, which is the basis for its inclusion in menopause blends, but no adequately controlled trial has tested alfalfa alone for hot flushes or any other menopausal outcome. Its estrogenic content is also a reason for caution rather than confidence in hormone-sensitive conditions.

  • Detoxifies or "purifies the blood" Limited evidence

    There is no clinical evidence behind this traditional claim at any dose, and no measured outcome — liver enzymes, toxin clearance, inflammatory markers — has been shown to improve with alfalfa supplementation in a controlled human study.

  • Provides safe general nutrition Limited evidence

    Alfalfa is nutrient-dense on paper, but the L-canavanine content is a genuine problem: this non-protein amino acid triggered a reversible lupus-like syndrome in primates and in human case reports, and alfalfa tablets have been reported to reactivate quiescent systemic lupus erythematosus. That distinguishes it from other green powders, which do not carry a documented autoimmune signal.

Dosage & safety

Studied doseTablets are typically sold at 500-1000 mg of leaf, 3-9 tablets daily; teas use 1-2 g of dried herb per cup. The only human study showing a lipid effect used about 120 g/day of prepared seeds — a food-scale intake that no tablet regimen approaches. There is no validated supplemental dose for any outcome.
SafetyThe central concern is L-canavanine, concentrated in seeds and sprouts and present in leaf material. It has been shown to induce autoimmune phenomena experimentally, and alfalfa seed or tablet ingestion has been linked to systemic lupus erythematosus flares and lupus-like syndromes in case reports; people with SLE, other autoimmune disease, or a family history should avoid alfalfa supplements entirely. Alfalfa is also very high in vitamin K and can antagonise warfarin, and its phytoestrogens argue for caution in hormone-sensitive cancers and with hormone therapy. Immunosuppressed people should avoid raw alfalfa sprouts specifically: they are one of the most frequent vehicles for Salmonella and E. coli outbreaks because the sprouting conditions incubate seed-borne pathogens, and washing does not reliably decontaminate them. Photosensitivity and GI upset are reported at higher intakes. Avoid in pregnancy given the estrogenic constituents and lack of safety data.

Scientific references

Where to buy

Pines International, Alfalfa, 500 Tablets

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in General health